Tuesday, 14 May 2019

FDA advisory panel votes against Daiichi Sankyo's cancer treatment

Independent experts on an FDA advisory panel on Tuesday voted against Daiichi Sankyo Co Ltd's treatment for adults with a type of acute myeloid leukemia.


No comments:

Post a Comment